Lectenz Bio, Inc.
Lectenz Bio, Inc. is a small business in Athens, GA registered on SAM.gov to bid on federal contracts. It has won 11 small business R&D awards worth $9.1 million through the SBIR and STTR programs since 2017, according to SBIR.gov.
- UEI
- JTGCK219C6F4
- CAGE code
- 4XHN3
- SAM.gov registration
- Active
Registration details
From SAM.gov's monthly public file dated Oct 5, 2026. If the business has updated its registration since, SAM.gov shows the newer details.
| Legal business name | Lectenz Bio, Inc. |
|---|---|
| Unique Entity ID (UEI) | JTGCK219C6F4 |
| CAGE code | 4XHN3 |
| Location | Athens, GA |
| SAM.gov registration | Active through Sep 15, 2027 |
| Business started | 2007 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
| Website | lectenz.com |
Certifications and business types
SAM.gov's public file from Oct 5, 2026 lists no SBA certification (8(a), HUBZone or WOSB) for Lectenz Bio, Inc.. The file sometimes leaves a certification out, and a newer one won't be in it yet: SBA's certification search and the firm's SAM.gov entry have the current list. SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
Lectenz Bio, Inc. has won 11 small business R&D awards worth $9.1 million through the SBIR and STTR programs since 2017, 4 of them Phase II. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Jul 18, 2025 | NIH | SBIR Phase I Innovative glycan-specific reagents to accelerate the detection of disease biomarkers | $313,827 |
| Sep 15, 2024 | NIH | SBIR Phase II Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment | $2 million |
| Sep 15, 2023 | NIH | SBIR Phase II A new approach to monitoring glycosylation during glycoprotein production | $2 million |
| Aug 1, 2023 | NIH | SBIR Phase I Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment | $301,703 |
| Mar 1, 2020 | NIH | SBIR Phase I Development of a suite of high-specificity fucose binding reagents | $450,000 |
| Mar 1, 2020 | NIH | SBIR Phase I Novel Reagents for Monitoring Sulfation Patterns in Heparin and Heparan Sulfate | $447,791 |
| Mar 1, 2020 | NIH | SBIR Phase II Pan-specific tools and reagents for the enrichment of sialo-glycans | $1.5 million |
| Sep 1, 2018 | NIH | SBIR Phase I Pan-specific tools and reagents for the enrichment of sialo-glycans | $224,934 |
Showing the newest 8. Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Lectenz Bio, Inc. is small under
On its SAM.gov registration, Lectenz Bio, Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Open contracts in Lectenz Bio, Inc.'s NAICS codes
27 open federal opportunities on SAM.gov use one of Lectenz Bio, Inc.'s NAICS codes and are open to it: no set-aside, or, in the code it is registered small under, a small business set-aside or one for a certification it holds. Here are a few, those in its primary code first (none of these are in Georgia right now), then the soonest due.
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Event or sign-up Oct 14, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (NIDA) is running a sources sought notice, not a solicitation, to find companies that can run, consolidate or recompete NIH biorepositories for FY 2028.
Due in 9 daysOct 20, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (through NIDA) is asking small businesses whether they can run one or more NIH biorepositories (sample banks) for FY 2028, including the NIDA Center for Genetic Studies and…
Due in 9 daysOct 20, 2026
- NAWCWD Broad Agency Announcement
Due in 19 daysOct 30, 2026
Similar small businesses
Other small businesses of a similar size with the same primary NAICS code (541714) that have won federal contracts. None in Georgia have yet, so these are in nearby states:
- Ixpressgenes, Inc., Huntsville, AL
- Transnetyx, Inc, Cordova, TN
- Aloft Biotechnologies, Inc, Alachua, FL
- Tolka.AI Inc, Miami, FL
- Radiant DX Inc., Durham, NC
- Polaris Quantum Biotech Inc, Cary, NC
Frequently asked questions
What is Lectenz Bio, Inc.'s CAGE code?
Lectenz Bio, Inc.'s CAGE code is 4XHN3. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Lectenz Bio, Inc.'s UEI?
Lectenz Bio, Inc.'s Unique Entity ID (UEI) is JTGCK219C6F4. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Lectenz Bio, Inc.'s SAM.gov registration active?
Yes, as of SAM.gov's public data from Oct 5, 2026, Lectenz Bio, Inc.'s registration is active through Sep 15, 2027. Registrations are renewed every year.
Is Lectenz Bio, Inc. a small business?
Lectenz Bio, Inc. is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To report a mistake on this page, or to ask us to remove it, email hello@fedready.us with the page address; we reply within 2 business days. For a removal, write from an address at the company.